Perminder Bhatia is a Neurology physician affiliated with Neuro Pain Medical Center. OpenAlex indexes 13 publications with 3,050 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
736 E Bullard Ave
#101
Fresno, CA 93710
Telephone
559-437-9700Registry record last updated 5 Aug 2009.
Industry payments
97 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202517 payments$17,958openpaymentsdata.cms.gov ↗
- Eisai Inc.Program year202528 payments$14,489openpaymentsdata.cms.gov ↗
- Axsome Therapeutics, Inc.Program year202522 payments$14,332openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
87.4%N-methyl-D-aspartate Receptor Antagonist20.6%Memantine Hcl99%Memantine Hcl Er1%Part D<11 patientsAromatic Amino Acid Decarboxylation Inhibitor11.3%Carbidopa-Levodopa48%Rytary32%Carbidopa-Levodopa Er20%Part D≥93 patients+ 26 more classes in this area
Musculoskeletal
4.3%Central alpha-2 Adrenergic Agonist1.3%Tizanidine Hcl100%Part D≥29 patientsNeuromuscular Blocker1.1%Botox75%Dysport25%Part D<11 patients+ 3 more classes in this area
Cardiovascular
3.1%Beta blocker2.3%Propranolol Hcl79%Propranolol Hcl Er21%Part D≥26 patientsAdrenergic and dopaminergic agents0.3%Droxidopa100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease
Annals of Internal Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”